These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14671428)

  • 1. Postantibiotic and sub-MIC effects of benzylpenicillin against Streptococcus pneumoniae with different susceptibilities for penicillin.
    Odenholt I; Gustafsson I; Löwdin E
    Chemotherapy; 2003 Dec; 49(6):287-93. PubMed ID: 14671428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
    Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
    Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2173-6. PubMed ID: 9333043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
    Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
    Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis.
    Kikuchi K; Enari T; Minami S; Haruki K; Shibata Y; Hasegawa H; Katahira J; Totsuka K; Shimizu K
    J Antimicrob Chemother; 1994 Nov; 34(5):687-96. PubMed ID: 7706164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations.
    Löwdin E; Odenholt-Tornqvist I; Bengtsson S; Cars O
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2200-5. PubMed ID: 8257145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
    Löwdin E; Odenholt I; Bengtsson S; Cars O
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2478-82. PubMed ID: 8913449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.
    Odenholt I; Gustafsson I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2003 Feb; 47(2):518-23. PubMed ID: 12543652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
    Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
    Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae.
    Kikuchi K; Totsuka K; Shimizu K; Ishii T; Yoshida T; Orikasa Y
    Microb Drug Resist; 1995; 1(2):185-9. PubMed ID: 9158754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation model.
    Fuentes F; Sevillano D; Balcabao IP; Gómez-Lus ML; Prieto J
    J Chemother; 2000 Dec; 12(6):495-8. PubMed ID: 11154032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2001 Jan; 45(1):23-9. PubMed ID: 11120939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro.
    Odenholt I; Holm SE; Cars O
    J Antimicrob Chemother; 1989 Aug; 24(2):147-56. PubMed ID: 2676938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
    Odenholt-Tornqvist I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1852-8. PubMed ID: 1329631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postantibiotic effect of ceftaroline against gram-positive organisms.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4537-9. PubMed ID: 19770288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
    Hanaki H; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1999 Sep; 52(9):563-70. PubMed ID: 10746191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.